Jeff E. Knight, Chief Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 9,911 shares at $37.77 ($370K) on 2026-03-16, disclosed to the SEC on 2026-03-18.
Scheduled sale ($370k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.11 | 5,950 | $221K | 59.6% |
| 2 | $37.77 | 3,961 | $150K | 40.4% |
| Total | $37.37 avg | 9,911 | $370K | 100% |
| Filing → |
| CRNX | SELL | 2024-11-26 | $28K | — | Filing → |
| CRNX | SELL | 2024-07-17 | $1.5M | — | Filing → |
| CRNX | SELL | 2024-06-28 | $42K | — | Filing → |